Chengzhi Shareholding Co Ltd (000990) - Net Assets
Based on the latest financial reports, Chengzhi Shareholding Co Ltd (000990) has net assets worth CN¥18.81 Billion CNY (≈ $2.75 Billion USD) as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥27.52 Billion ≈ $4.03 Billion USD) and total liabilities (CN¥8.72 Billion ≈ $1.28 Billion USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check 000990 asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | CN¥18.81 Billion |
| % of Total Assets | 68.33% |
| Annual Growth Rate | 21.95% |
| 5-Year Change | 12.19% |
| 10-Year Change | 614.16% |
| Growth Volatility | 106.4 |
Chengzhi Shareholding Co Ltd - Net Assets Trend (1997–2024)
This chart illustrates how Chengzhi Shareholding Co Ltd's net assets have evolved over time, based on quarterly financial data. Also explore Chengzhi Shareholding Co Ltd balance sheet assets for the complete picture of this company's asset base.
Annual Net Assets for Chengzhi Shareholding Co Ltd (1997–2024)
The table below shows the annual net assets of Chengzhi Shareholding Co Ltd from 1997 to 2024. For live valuation and market cap data, see Chengzhi Shareholding Co Ltd stock valuation.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | CN¥18.73 Billion ≈ $2.74 Billion |
+1.46% |
| 2023-12-31 | CN¥18.46 Billion ≈ $2.70 Billion |
-0.27% |
| 2022-12-31 | CN¥18.51 Billion ≈ $2.71 Billion |
+0.27% |
| 2021-12-31 | CN¥18.46 Billion ≈ $2.70 Billion |
+10.57% |
| 2020-12-31 | CN¥16.70 Billion ≈ $2.44 Billion |
+2.16% |
| 2019-12-31 | CN¥16.34 Billion ≈ $2.39 Billion |
+0.13% |
| 2018-12-31 | CN¥16.32 Billion ≈ $2.39 Billion |
+1.60% |
| 2017-12-31 | CN¥16.07 Billion ≈ $2.35 Billion |
+3.53% |
| 2016-12-31 | CN¥15.52 Billion ≈ $2.27 Billion |
+491.62% |
| 2015-12-31 | CN¥2.62 Billion ≈ $383.83 Million |
+11.99% |
| 2014-12-31 | CN¥2.34 Billion ≈ $342.75 Million |
+38.31% |
| 2013-12-31 | CN¥1.69 Billion ≈ $247.82 Million |
+2.61% |
| 2012-12-31 | CN¥1.65 Billion ≈ $241.51 Million |
-0.35% |
| 2011-12-31 | CN¥1.66 Billion ≈ $242.36 Million |
+1.54% |
| 2010-12-31 | CN¥1.63 Billion ≈ $238.68 Million |
-2.49% |
| 2009-12-31 | CN¥1.67 Billion ≈ $244.78 Million |
+24.35% |
| 2008-12-31 | CN¥1.35 Billion ≈ $196.85 Million |
+31.41% |
| 2007-12-31 | CN¥1.02 Billion ≈ $149.80 Million |
+2.60% |
| 2006-12-31 | CN¥997.75 Million ≈ $146.00 Million |
+2.26% |
| 2005-12-31 | CN¥975.70 Million ≈ $142.78 Million |
+4.90% |
| 2004-12-31 | CN¥930.16 Million ≈ $136.11 Million |
+10.79% |
| 2003-12-31 | CN¥839.58 Million ≈ $122.86 Million |
+7.10% |
| 2002-12-31 | CN¥783.92 Million ≈ $114.71 Million |
+8.94% |
| 2001-12-31 | CN¥719.56 Million ≈ $105.29 Million |
+8.44% |
| 2000-12-31 | CN¥663.54 Million ≈ $97.10 Million |
+313.36% |
| 1999-12-31 | CN¥160.52 Million ≈ $23.49 Million |
+24.37% |
| 1998-12-31 | CN¥129.07 Million ≈ $18.89 Million |
+46.42% |
| 1997-12-31 | CN¥88.15 Million ≈ $12.90 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Chengzhi Shareholding Co Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 362405737300.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | CN¥3.62 Billion | 20.32% |
| Common Stock | CN¥1.22 Billion | 6.81% |
| Other Comprehensive Income | CN¥588.10 Million | 3.30% |
| Other Components | CN¥12.41 Billion | 69.56% |
| Total Equity | CN¥17.83 Billion | 100.00% |
Chengzhi Shareholding Co Ltd Competitors by Market Cap
The table below lists competitors of Chengzhi Shareholding Co Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Wondershare Technology Co Ltd Class A
SHE:300624
|
$2.00 Billion |
|
Wuxi Dk Electronic Materials Co Ltd
SHE:300842
|
$2.00 Billion |
|
Genesis Energy LP
NYSE:GEL
|
$2.00 Billion |
|
Northking Information Technology Co
SHE:002987
|
$2.00 Billion |
|
Shanghai Jahwa United Co Ltd
SHG:600315
|
$2.00 Billion |
|
Entra ASA
OL:ENTRA
|
$2.00 Billion |
|
Establishment Labs Holdings Inc
NASDAQ:ESTA
|
$2.00 Billion |
|
Sigdo Koppers
SN:SK
|
$2.00 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Chengzhi Shareholding Co Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 17,650,708,059 to 17,832,498,223, a change of 181,790,164 (1.0%).
- Net income of 230,588,927 contributed positively to equity growth.
- Dividend payments of 226,550,594 reduced retained earnings.
- Other comprehensive income increased equity by 599,612,060.
- Other factors decreased equity by 421,860,229.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | CN¥230.59 Million | +1.29% |
| Dividends Paid | CN¥226.55 Million | -1.27% |
| Other Comprehensive Income | CN¥599.61 Million | +3.36% |
| Other Changes | CN¥-421.86 Million | -2.37% |
| Total Change | CN¥- | 1.03% |
Book Value vs Market Value Analysis
This analysis compares Chengzhi Shareholding Co Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.77x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has decreased from 21.09x to 0.77x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 1997-12-31 | CN¥0.53 | CN¥11.26 | x |
| 1998-12-31 | CN¥0.76 | CN¥11.26 | x |
| 1999-12-31 | CN¥0.95 | CN¥11.26 | x |
| 2000-12-31 | CN¥4.24 | CN¥11.26 | x |
| 2001-12-31 | CN¥4.45 | CN¥11.26 | x |
| 2002-12-31 | CN¥4.74 | CN¥11.26 | x |
| 2003-12-31 | CN¥5.12 | CN¥11.26 | x |
| 2004-12-31 | CN¥5.38 | CN¥11.26 | x |
| 2005-12-31 | CN¥5.63 | CN¥11.26 | x |
| 2006-12-31 | CN¥3.59 | CN¥11.26 | x |
| 2007-12-31 | CN¥3.75 | CN¥11.26 | x |
| 2008-12-31 | CN¥4.75 | CN¥11.26 | x |
| 2009-12-31 | CN¥5.51 | CN¥11.26 | x |
| 2010-12-31 | CN¥5.31 | CN¥11.26 | x |
| 2011-12-31 | CN¥5.39 | CN¥11.26 | x |
| 2012-12-31 | CN¥5.43 | CN¥11.26 | x |
| 2013-12-31 | CN¥5.57 | CN¥11.26 | x |
| 2014-12-31 | CN¥7.25 | CN¥11.26 | x |
| 2015-12-31 | CN¥6.35 | CN¥11.26 | x |
| 2016-12-31 | CN¥39.45 | CN¥11.26 | x |
| 2017-12-31 | CN¥12.69 | CN¥11.26 | x |
| 2018-12-31 | CN¥12.91 | CN¥11.26 | x |
| 2019-12-31 | CN¥13.28 | CN¥11.26 | x |
| 2020-12-31 | CN¥13.57 | CN¥11.26 | x |
| 2021-12-31 | CN¥14.53 | CN¥11.26 | x |
| 2022-12-31 | CN¥14.54 | CN¥11.26 | x |
| 2023-12-31 | CN¥14.53 | CN¥11.26 | x |
| 2024-12-31 | CN¥14.67 | CN¥11.26 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Chengzhi Shareholding Co Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 1.29%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 2.08%
- • Asset Turnover: 0.41x
- • Equity Multiplier: 1.52x
- Recent ROE (1.29%) is below the historical average (5.84%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 1997 | 25.29% | 8.93% | 1.52x | 1.86x | CN¥12.22 Million |
| 1998 | 20.51% | 10.00% | 1.09x | 1.89x | CN¥11.92 Million |
| 1999 | 19.90% | 14.07% | 0.75x | 1.90x | CN¥14.01 Million |
| 2000 | 6.37% | 14.73% | 0.35x | 1.24x | CN¥-23.02 Million |
| 2001 | 6.77% | 10.27% | 0.48x | 1.39x | CN¥-21.48 Million |
| 2002 | 7.79% | 6.82% | 0.58x | 1.99x | CN¥-15.68 Million |
| 2003 | 7.31% | 3.85% | 0.91x | 2.08x | CN¥-20.58 Million |
| 2004 | 5.96% | 4.30% | 0.67x | 2.08x | CN¥-32.50 Million |
| 2005 | 5.91% | 3.55% | 0.73x | 2.27x | CN¥-34.50 Million |
| 2006 | 5.87% | 3.61% | 0.63x | 2.57x | CN¥-35.77 Million |
| 2007 | 5.62% | 2.58% | 0.87x | 2.49x | CN¥-39.71 Million |
| 2008 | 2.23% | 1.09% | 0.88x | 2.31x | CN¥-95.81 Million |
| 2009 | 2.58% | 1.43% | 0.77x | 2.35x | CN¥-116.88 Million |
| 2010 | 1.37% | 0.69% | 0.89x | 2.26x | CN¥-135.21 Million |
| 2011 | 1.98% | 1.06% | 0.89x | 2.10x | CN¥-127.93 Million |
| 2012 | 1.69% | 0.81% | 1.12x | 1.89x | CN¥-133.58 Million |
| 2013 | 3.14% | 1.30% | 1.20x | 2.02x | CN¥-113.17 Million |
| 2014 | 3.16% | 1.83% | 1.02x | 1.69x | CN¥-158.62 Million |
| 2015 | 5.67% | 3.41% | 0.82x | 2.03x | CN¥-105.42 Million |
| 2016 | 0.72% | 4.30% | 0.13x | 1.32x | CN¥-1.42 Billion |
| 2017 | 5.08% | 14.20% | 0.27x | 1.32x | CN¥-781.83 Million |
| 2018 | 5.25% | 14.47% | 0.25x | 1.45x | CN¥-768.65 Million |
| 2019 | 2.74% | 6.40% | 0.29x | 1.49x | CN¥-1.17 Billion |
| 2020 | 2.15% | 3.65% | 0.40x | 1.48x | CN¥-1.29 Billion |
| 2021 | 5.71% | 8.28% | 0.50x | 1.38x | CN¥-756.73 Million |
| 2022 | 0.29% | 0.43% | 0.48x | 1.39x | CN¥-1.72 Billion |
| 2023 | 1.01% | 1.43% | 0.48x | 1.46x | CN¥-1.59 Billion |
| 2024 | 1.29% | 2.08% | 0.41x | 1.52x | CN¥-1.55 Billion |
Industry Comparison
This section compares Chengzhi Shareholding Co Ltd's net assets metrics with peer companies in the Biotechnology industry.
Industry Context
- Industry: Biotechnology
- Average net assets among peers: $2,332,313,852
- Average return on equity (ROE) among peers: 8.30%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Chengzhi Shareholding Co Ltd (000990) | CN¥18.81 Billion | 25.29% | 0.46x | $2.00 Billion |
| Shenzhen CAU Technology Co Ltd (000004) | $85.28 Million | -13.04% | 0.97x | $53.47 Million |
| Pacific Shuanglin Bio pharmacy Co Ltd (000403) | $64.35 Million | 12.98% | 2.10x | $1.63 Billion |
| Nanhua Bio Medicine Co Ltd (000504) | $449.00 Million | 0.82% | 0.52x | $456.85 Million |
| Jiangsu Sihuan Bioengineering Co Ltd (000518) | $1.10 Billion | 6.29% | 0.12x | $467.03 Million |
| Hualan Biological EngineeringInc (002007) | $13.42 Billion | 11.04% | 0.20x | $3.89 Billion |
| Da An Gene Co Ltd of Sun Yat-Sen University (002030) | $256.72 Million | 9.82% | 0.22x | $1.36 Billion |
| Shanghai RAAS Blood Products Co Ltd Class A (002252) | $831.21 Million | 22.32% | 0.12x | $5.52 Billion |
| Baolingbao Biology Co Ltd (002286) | $1.57 Billion | 2.25% | 0.61x | $575.82 Million |
| Tibet Cheezheng Tibetan Medicine Co Ltd (002287) | $3.22 Billion | 22.23% | 0.73x | $1.93 Billion |
About Chengzhi Shareholding Co Ltd
Chengzhi Co., Ltd. engages in the clean energy, semiconductor display material, medical healthcare, and life science businesses in China. The company produces and sells gas products, including carbon monoxide, syngas, butane, isobutanal, ethane, propane, crude benzene, ethylene, hydrogen, propylene, methanol, butylene glycol, Butanoctyl, diolefin, and other chemicals. It also produces and sells l… Read more